Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.
暂无分享,去创建一个
Morteza Mahmoudi | Stuart Goodman | Michael Moseley | G. Hutter | M. Moseley | L. Coussens | H. Daldrup-Link | Aubie K. Shaw | R. Spitler | M. Mahmoudi | S. Goodman | H. Nejadnik | Saeid Zanganeh | Olga D. Lenkov | Ryan Spitler | Hossein Nejadnik | J. Pajarinen | Saeid Zanganeh | Gregor Hutter | Olga Lenkov | Aubie Shaw | Jukka Sakari Pajarinen | Lisa Marie Coussens | Heike Elisabeth Daldrup-Link | Aubie Shaw
[1] Ralph Weissleder,et al. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug , 2015, Nature Communications.
[2] Yaping Tian,et al. Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment. , 2015, Cancer letters.
[3] B. Faddegon,et al. TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy , 2015, Cancer Immunology Research.
[4] E. Marbán,et al. Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting , 2014, Nature Communications.
[5] Will Liao,et al. The cellular and molecular origin of tumor-associated macrophages , 2014, Science.
[6] S. Vinogradov,et al. Macrophages associated with tumors as potential targets and therapeutic intermediates. , 2014, Nanomedicine.
[7] M. Moseley,et al. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. , 2014, The Lancet. Oncology.
[8] Jianghong Rao,et al. Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. , 2014, Small.
[9] R. Weissleder,et al. Imaging macrophages with nanoparticles. , 2014, Nature materials.
[10] Chun Li,et al. A targeted approach to cancer imaging and therapy. , 2014, Nature materials.
[11] Jan Grimm,et al. Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle , 2014, Nature Communications.
[12] F. Klamt,et al. The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer. , 2014, Histology and histopathology.
[13] J. Witjes,et al. Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection? , 2013, European urology.
[14] U. Kolb,et al. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD). , 2013, Journal of pharmaceutical and biomedical analysis.
[15] A. Butte,et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. , 2013, Cancer discovery.
[16] Wei Li,et al. SPION primes THP1 derived M2 macrophages towards M1-like macrophages. , 2013, Biochemical and biophysical research communications.
[17] Harald Ittrich,et al. Superparamagnetic Iron Oxide Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
[18] W. Reinisch,et al. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[19] H. Daldrup-Link,et al. Somatic Differentiation and MR Imaging of Magnetically Labeled Human Embryonic Stem Cells , 2012, Cell transplantation.
[20] Z. Liao,et al. Feasibility and safety of magnetic-controlled capsule endoscopy system in examination of human stomach: a pilot study in healthy volunteers. , 2012, Journal of interventional gastroenterology.
[21] C. A. Shaw,et al. In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans , 2012, Circulation Cardiovascular Imaging.
[22] L. Coussens,et al. MR imaging of tumor-associated macrophages , 2012, Oncoimmunology.
[23] Andrew H. Beck,et al. Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma , 2012, Proceedings of the National Academy of Sciences.
[24] Tej B. Shrestha,et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model , 2012, International journal of nanomedicine.
[25] V. Labhasetwar,et al. Oh the irony: Iron as a cancer cause or cure? , 2011, Biomaterials.
[26] M. Kuo,et al. Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy. , 2011, ACS nano.
[27] M. Rosner,et al. Ferumoxytol for the treatment of iron deficiency , 2011, Expert review of hematology.
[28] M. Wendland,et al. MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles , 2011, Clinical Cancer Research.
[29] K. Bhalla,et al. Histone Deacetylase Inhibitor LAQ824 Augments Inflammatory Responses in Macrophages through Transcriptional Regulation of IL-10 , 2011, The Journal of Immunology.
[30] Cord Sunderkötter,et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.
[31] J. Tidball,et al. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. , 2011, Human molecular genetics.
[32] M. Grce,et al. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[33] V. Rasche,et al. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. , 2010, Biomaterials.
[34] C. Hadjipanayis,et al. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. , 2010, Cancer research.
[35] A. Kausz,et al. Plasma Pharmacokinetics of Two Consecutive Doses of Ferumoxytol in Healthy Subjects , 2010, Clinical pharmacology and therapeutics.
[36] P. Allavena,et al. Tumor-Associated Macrophages (TAM) as Major Players of the Cancer-Related Inflammation , 2010 .
[37] R. Pazdur,et al. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease , 2010, American journal of hematology.
[38] Andrew T Nguyen,et al. A Combinatorial Approach for Targeted Delivery using Small Molecules and Reversible Masking to Bypass Non-Specific Uptake In Vivo , 2010, Gene Therapy.
[39] A. Kausz,et al. Physicochemical properties of ferumoxytol, a new intravenous iron preparation , 2009, European journal of clinical investigation.
[40] F. Benvenuto,et al. Ascorbic acid pre-treated quartz stimulates TNF-α release in RAW 264.7 murine macrophages through ROS production and membrane lipid peroxidation , 2009, Respiratory research.
[41] A. Kristal,et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. , 2008, Carcinogenesis.
[42] R. Proia,et al. Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages , 2008, Circulation research.
[43] Michael Jerosch-Herold,et al. THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY: A PILOT STUDY , 2007, Neurosurgery.
[44] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[45] Guangjun Nie,et al. In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin. , 2006, Blood.
[46] M. Glei,et al. Ferric iron increases ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[47] W. K. Bolton,et al. Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis Patients , 2005, American Journal of Nephrology.
[48] D. Wodarz,et al. Dynamical Interactions between Multiple Cancers , 2005, Cell cycle.
[49] D. Petersen. Alcohol, iron-associated oxidative stress, and cancer. , 2005, Alcohol.
[50] P. Ponka,et al. Human cytomegalovirus-induced host cell enlargement is iron dependent. , 2004, American journal of physiology. Cell physiology.
[51] A. Gupta,et al. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies , 2004, IEEE Transactions on NanoBioscience.
[52] C. Tempany,et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. , 2003, Radiology.
[53] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[54] D. Warheit,et al. Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: Comparisons among rodent species , 1993, Microscopy research and technique.